THERAPY WITH HYBRID ANTIBODIES

THERAPY WITH HYBRID ANTIBODIES

Detalhes bibliográficos
Main Authors:	Clark, M, Waldmann, H
Formato:	Journal article
Publicado em:	1989

Registos relacionados

Hybrid antibodies for therapy.
Por: Clark, M, et al.
Publicado em: (1988)

THE POTENTIAL OF HYBRID ANTIBODIES SECRETED BY HYBRID-HYBRIDOMAS IN TUMOR-THERAPY
Por: Clark, M, et al.
Publicado em: (1987)

The potential of hybrid antibodies secreted by hybrid-hybridomas in tumour therapy.
Por: Clark, M, et al.
Publicado em: (1988)

T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies.
Por: Clark, MR, et al.
Publicado em: (1987)

Reshaping human antibodies for therapy.
Por: Riechmann, L, et al.
Publicado em: (1988)

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
Por: Isaacs, J, et al.
Publicado em: (1992)

Monoclonal-antibody therapy in systemic vasculitis.
Por: Mathieson, P, et al.
Publicado em: (1990)

Induction of tolerance by monoclonal antibody therapy.
Por: Benjamin, R, et al.
Publicado em: (1986)

MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
Por: Mathieson, P, et al.
Publicado em: (1990)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
Por: Dyer, M, et al.
Publicado em: (1988)

Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.
Por: Hale, G, et al.
Publicado em: (1985)

Advantages of rat monoclonal antibodies.
Por: Clark, M, et al.
Publicado em: (1983)

Interaction of rat monoclonal antibodies with human killer cells.
Por: Clark, M, et al.
Publicado em: (1985)

Structural motifs involved in human IgG antibody effector functions.
Por: Greenwood, J, et al.
Publicado em: (1993)

INTERACTION OF RAT MONOCLONAL-ANTIBODIES WITH HUMAN KILLER CELLS (K-CELLS)
Por: Hale, G, et al.
Publicado em: (1984)

Human monoclonal antibodies: the residual challenge of antibody immunogenicity.
Por: Waldmann, H
Publicado em: (2014)

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.
Por: Cobbold, S, et al.
Publicado em: (1984)

Tolerance to rat monoclonal antibodies. Implications for serotherapy.
Por: Benjamin, R, et al.
Publicado em: (1986)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
Por: Isaacs, J, et al.
Publicado em: (1992)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
Por: Isaacs, J, et al.
Publicado em: (1992)

Immunohistological screening in the selection of monoclonal antibodies: the use of isotype-specific antiglobulins.
Por: Aqel, N, et al.
Publicado em: (1984)

Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells.
Por: Gilliland, L, et al.
Publicado em: (1988)

Blocking of cytotoxic T cell function by monoclonal antibodies against the CD45 antigen (T200/leukocyte-common antigen).
Por: Tighe, H, et al.
Publicado em: (1987)

Reshaping a therapeutic CD4 antibody.
Por: Gorman, S, et al.
Publicado em: (1991)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
Por: Lockwood, C, et al.
Publicado em: (1993)

Prospects for the application of antibodies in medicine.
Por: Waldmann, H
Publicado em: (2000)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Por: Lockwood, C, et al.
Publicado em: (1993)

Manipulation of T-cell responses with monoclonal antibodies.
Por: Waldmann, H
Publicado em: (1989)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
Por: Lim, S, et al.
Publicado em: (1993)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
Por: Hale, G, et al.
Publicado em: (1989)

Therapeutic potential of monoclonal antibodies to the leukocyte-common antigen. Synergy and interference in complement-mediated lysis.
Por: Bindon, C, et al.
Publicado em: (1985)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
Por: Lockwood, C, et al.
Publicado em: (1995)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
Por: Isaacs, J, et al.
Publicado em: (1998)

Monoclonal antibodies for organ transplantation: prospects for the future.
Por: Waldmann, H
Publicado em: (1988)

Identification of cells of the human mononuclear phagocyte system with rat monoclonal antibodies.
Por: Aqel, N, et al.
Publicado em: (1987)

IDENTIFICATION OF CELLS OF THE HUMAN MONONUCLEAR PHAGOCYTE SYSTEM WITH RAT MONOCLONAL-ANTIBODIES
Por: Aqel, N, et al.
Publicado em: (1987)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
Por: Cobbold, S, et al.
Publicado em: (1990)

Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms.
Por: Cobbold, S, et al.
Publicado em: (1990)

Detection of monoclonal antibodies against cell surface antigens: the use of antiglobulins coupled to red blood cells.
Por: Clark, MR, et al.
Publicado em: (1984)

Monoclonal antibodies for the induction of transplantation tolerance.
Por: Waldmann, H, et al.
Publicado em: (1993)